Ticker Details
Vanda Pharmaceuticals Inc. Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.
IPO Date:	April 12, 2006
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$340.46M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.24 | 2.39%
Avg Daily Range (30 D):	$0.20 | 2.77%
Avg Daily Range (90 D):	$0.18 | 2.75%

Institutional Daily Volume
Avg Daily Volume:	.6M
Avg Daily Volume (30 D):	2.81M
Avg Daily Volume (90 D):	1.98M

Trade Size
Avg Trade Size (Sh.):	142
Avg Trade Size (Sh.) (30 D):	119
Avg Trade Size (Sh.) (90 D):	122

Institutional Trades
Total Institutional Trades:	3,149
Avg Institutional Trade:	$1.49M
Avg Institutional Trade (30 D):	$.76M
Avg Institutional Trade (90 D):	$.87M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.55M
Avg Closing Trade (30 D):	$.72M
Avg Closing Trade (90 D):	$.8M
Avg Closing Volume:	120.85K

News

Dec 31, 2025 @ 9:09 AM Stock Market Today: S&P 500, Dow Jones Futures Dow... Source: Vishaal Sanjay

Oct 27, 2025 @ 5:00 PM Gastroparesis Market Poised for Extraordinary Grow... Source: Delveinsight

Aug 1, 2025 @ 8:18 AM Vanda (VNDA) Q2 Revenue Rises 4% Source: Jesterai

Oct 9, 2024 @ 5:00 PM Schizophrenia Clinical Trial Pipeline Insights Fea... Source: Delveinsight

Jun 7, 2024 @ 10:02 AM Vanda (VNDA) Surges 24.2%: Is This an Indication o... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.74	$-2.39	$-3.74
Diluted EPS	$-3.74	$-2.39	$-3.74
Revenue	$216.11M	$57.22M	$216.11M
Gross Profit
Net Income / Loss	$-220.47M	$-141.19M	$-220.47M
Operating Income / Loss	$-151.17M	$-40.35M	$-151.17M
Cost of Revenue
Net Cash Flow	$-17.47M	$14.83M	$-17.47M
PE Ratio